- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06435130
The Impact of Chokeberry Bioproducts on Metabolic Parameters and Antioxidant Potential
May 23, 2024 updated by: Małgorzata Zujko, Medical University of Bialystok
The Impact of Chokeberry Bioproducts Consumption on Metabolic Parameters and the Antioxidant Potential of Serum
Chokeberry can be used both in the prevention and treatment of various metabolic disorders due to its high antioxidant properties.
The study assessed for the first time the synergistic effect of chokeberry juice and chokeberry fiber on selected metabolic and anthropometric parameters.
102 people (67 women and 35 men) took part in the intervention study.
After 8 weeks of intervention with chokeberry juice and another 4 weeks of intervention with chokeberry juice and fiber, a change in waist circumference, blood pressure, glucose, glycated hemoglobin, LDL cholesterol, aspartate transaminase (AST) and the level of antioxidant potential was observed.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
102
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Białystok, Poland, 15-089
- Medical University of Bialystok
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- age 30-65 years,
- low or moderate physical activity.
Exclusion Criteria:
- age <30 and >65 years,
- high physical activity,
- obesity (class II),
- diabetes (all types),
- gastric ulcer,
- acute or chronic gastritis,
- intestinal diseases, including inflammatory bowel diseases and functional intestinal disorders,
- taking hypoglycemic, lipid-lowering, immunosuppressive, anticoagulant and antihypertensive drugs, use of steroid therapy,
- high physical activity,
- pregnancy,
- breastfeeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Dietary intervention with chokeberry juice and fibre
Study participants consumed 100 mL of chokeberry juice daily for 8 weeks.
After 8 weeks, participants consumed 100 ml of chokeberry juice and 10 g of chokeberry fiber daily for 4 weeks.
|
The first stage of the dietary intervention lasted 8 weeks.
Study participants consumed 100 ml of chokeberry juice daily.
Chokeberry juice came from ecological cultivation (Poland).
Participants qualified for the study had specific biochemical parameters tested: fasting glucose and insulin level, lipid profile (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol), glycated hemoglobin, uric acid, C-reactive protein (CRP), creatinine, liver enzymes: alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamylotranspeptydase (GGTP), homocysteine and antioxidant potential.
Blood tests were performed in a certified external laboratory before and after 8 weeks of intervention.
In addition, blood pressure and waist circumference were tested.
The second stage of the dietary intervention lasted 4 weeks.
Study participants consumed 100 ml of chokeberry juice daily and 10 g chokeberry fiber daily (from ecological cultivation, Poland).
Blood tests were performed in a certified external laboratory after 4 weeks of intervention.
The following blood tests were performed: fasting glucose and insulin level, lipid profile (triglycerides, total cholesterol, LDL-cholesterol, HDL-cholesterol), glycated hemoglobin, uric acid, C-reactive protein (CRP), creatinine, liver enzymes: alanine transaminase (ALT), aspartate transaminase (AST), gamma-glutamylotranspeptydase (GGTP), homocysteine and antioxidant potential.
In addition, blood pressure and waist circumference were tested.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in waist circumference
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in waist circumference was observed.
|
12 weeks
|
|
Change in blood pressure
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in systolic and diastolic blood pressure was observed.
|
12 weeks
|
|
Change in glycated hemoglobin
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in glycated hemoglobin was observed.
|
12 weeks
|
|
Change in glucose level
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in glucose level was observed.
|
12 weeks
|
|
Change in LDL-cholesterol
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in LDL-cholesterol level was observed.
|
12 weeks
|
|
Change in aspartate transaminase (AST) level
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in aspartate transaminase (AST) level was observed.
|
12 weeks
|
|
Change in antioxidant potential of serum
Time Frame: 12 weeks
|
After 8 weeks of using chokeberry juice-100 mL daily and another 4 weeks of using chokeberry juice - 100 mL daily and chokeberry fiber - 10 g daily, a change in antioxidant potential of serum was observed.
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Malgorzata E. Zujko, Dr., Medical University of Bialystok
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2022
Primary Completion (Actual)
August 30, 2022
Study Completion (Actual)
August 30, 2022
Study Registration Dates
First Submitted
May 20, 2024
First Submitted That Met QC Criteria
May 23, 2024
First Posted (Actual)
May 30, 2024
Study Record Updates
Last Update Posted (Actual)
May 30, 2024
Last Update Submitted That Met QC Criteria
May 23, 2024
Last Verified
May 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MUBialystok2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Franz Rischard, DOAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway...Not yet recruitingPulmonary Hypertension | Pulmonary Arterial Hypertension (PAH)United States
-
Abant Izzet Baysal UniversityNot yet recruitingPRIMARY HYPERTENSIONTurkey (Türkiye)
-
SingHealth PolyclinicsNanyang PolytechnicEnrolling by invitationHypertension,EssentialSingapore
-
Hacettepe UniversityBozok UniversityCompletedHypertension | Arterial Hypertension | Systemic HypertensionTurkey (Türkiye)
-
BackBeat Medical IncNot yet recruitingHypertension, Systolic | Hypertension (HTN) | Heart Failure With Preserved Ejection Fraction (HFpEFGeorgia
-
Xuanwu Hospital, BeijingNot yet recruiting
-
Shenzhen Salubris Pharmaceuticals Co., Ltd.Not yet recruiting
-
Instituto de Cardiologia do Rio Grande do SulCompletedHypertension (HTN) | Hypertension ArterialBrazil
Clinical Trials on Dietary intervention with chokeberry juices
-
Poznan University of Physical EducationCompletedIntestinal Permeability | Stress OxidativePoland
-
Poznan University of Physical EducationCompletedInflammation | Oxidative Stress | Female Athlete Triad | Iron DeficienciesPoland
-
KU LeuvenCompletedGastric Emptying | Energy Intake | Satiety | Appetite | Glucose Response | Insulin ResponseBelgium
-
Chiang Mai UniversityCompleted
-
Wageningen University and ResearchAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); FrieslandCampina... and other collaboratorsRecruitingFunctional ConstipationNetherlands
-
KU LeuvenRecruitingBody Weight Changes | Overweight and Obesity | Eating Behavior | Appetite Regulation | Energy IntakeBelgium
-
University of Illinois at ChicagoUniversity of Chicago; The Broad FoundationCompletedUlcerative ColitisUnited States
-
Peking University First HospitalUnknownGestational Diabetes Mellitus (GDM)China
-
University Hospital TuebingenDLR German Aerospace CenterEnrolling by invitationBed Rest | Space AnalogueGermany
-
The Cleveland ClinicRecruitingCardiovascular Risk Factor | Dietary ModificationUnited States